Evidence map›Paper›PMID 30885933›Full record

ReviewJournal of bacteriology2019

The Yin and Yang of

Jessie E Scott, George A O'Toole

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of bacteriology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Co-infection withISME communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Dpr-mediated HJournal of bacteriology · 2024
    Article
  8. An energy coupling factor transporter ofbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Effect ofFrontiers in microbiology · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Commensal Bacteria in the Cystic Fibrosis Airway Microbiome ReduceFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Pseudomonas aeruginosa in the Cystic Fibrosis Lung.Advances in experimental medicine and biology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jessie E ScottDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA georgeo@Dartmouth.edu.
Dartmouth College · US

Funding

Molecular and Cellular Biology at DartmouthT32GM008704 · NIGMS · DARTMOUTH COLLEGE · PI COMPTON, DUANE A. · 1998 to 2018
$6.8M
cdiGMP regulation of Biofilm FormationR37AI083256 · NIAID · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2014 to 2023
$4.7M
NIAID NIH HHS R37 AI083256NIGMS NIH HHS T32 GM008704
6 · The paper itself

Abstract

The streptococci are increasingly recognized as a core component of the cystic fibrosis (CF) lung microbiome, yet the role that they play in CF lung disease is unclear. The presence of the

Indexed as

Anti-Bacterial AgentsBiofilmsCoinfectionCystic FibrosisGene ExpressionHumansLungMicrobial InteractionsModels, BiologicalPneumococcal InfectionsPseudomonas aeruginosaPseudomonas InfectionsStreptococcus milleri GroupVirulenceVirulence FactorsAnti-Bacterial AgentsVirulence Factorscystic fibrosisexacerbationpolymicrobialStreptococcusStreptococcus milleri group

Identifiers

PMID30885933
PMCPMC6509657
OpenAlexW2921407799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.